QuidelOrtho Corporation (LON:0A55)

Market Cap	2.15B
Revenue (ttm)	2.21B
Net Income (ttm)	-1.61B
Shares Out	n/a
EPS (ttm)	-23.96
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2
Average Volume	177
Open	43.09
Previous Close	43.64
Day's Range	43.09 - 43.50
52-Week Range	41.71 - 96.85
Beta	n/a
RSI	49.59
Earnings Date	Feb 12, 2025

About QuidelOrtho

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease,...

• Industry: Medical - Specialties
• Sector: Healthcare
• Founded: 1979
• Employees: 7,100
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A55

Financial Performance

In 2024, QuidelOrtho's revenue was $2.78 billion, a decrease of -7.17% compared to the previous year's $3.00 billion. Losses were -$2.03 billion, 19969.3% more than in 2023.

Financial numbers in USD